fusaric acid has been researched along with Adrenal Cancer in 2 studies
Fusaric Acid: A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimpo, S | 1 |
| Sakata, K | 1 |
| Kawashimo, K | 1 |
| Kanagi, R | 1 |
| Omori, Y | 1 |
| Kawahara, H | 1 |
| Kuzutani, F | 1 |
| Mizuno, S | 1 |
2 other studies available for fusaric acid and Adrenal Cancer
| Article | Year |
|---|---|
[Treatment of pheochromocytoma with fusaric acid].
Topics: Adrenal Gland Neoplasms; Adult; Female; Fusaric Acid; Humans; Male; Middle Aged; Pheochromocytoma; P | 1976 |
[Proceedings: Case of pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Fusaric Acid; Humans; Male; Middle Aged; Pheochromocytoma; Picolinic Acids | 1975 |